• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON AND COMPANY, BD BIOSCIENCES BD FACSCANTO¿ II; COUNTER, DIFFERENTIAL CELL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON AND COMPANY, BD BIOSCIENCES BD FACSCANTO¿ II; COUNTER, DIFFERENTIAL CELL Back to Search Results
Catalog Number 338962
Medical Device Problem Code Contamination of Device Ingredient or Reagent (2901)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 01/28/2025
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
H.3.A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event or Problem Description
It was reported that while using bd facscanto¿ ii carryover between patient samples was observed.There was no patient impact reported.The following information was provided by the initial reporter: cx called reporting a carryover problem with this instrument.Carryover noticed on a 2 sample run.It was caught.No false reporting based on this carryover.
 
Event or Problem Description
It was reported that while using bd facscanto¿ ii carryover between patient samples was observed.There was no patient impact reported.The following information was provided by the initial reporter: cx called reporting a carryover problem with this instrument.-carryover noticed on a 2 sample run.It was caught.No false reporting based on this carryover.
 
Additional Manufacturer Narrative
H.6 investigation summary: based on the investigation results, the reported issue of carryover was confirmed.Investigation results that were performed on the indicated failure mode were the following: the complaint trend and service notes were reviewed.The potential cause for the customer experiencing carryover linked to the clogged tubing in the fluidic system.No parts were replaced.No further problems were noted, and the instrument was confirmed to be functioning as expected.Although the instrument was used for diagnostic testing, the issue was resolved before the patient sample results were used for any diagnosis or treatment.Complaints received for this device and reported condition will continue to be tracked and trended.Information will be captured on trend reports and monitored.Our business team regularly reviews the collected data for identification of emerging trends.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD FACSCANTO¿ II
Common Device Name
COUNTER, DIFFERENTIAL CELL
Manufacturer (Section D)
BECTON, DICKINSON AND COMPANY, BD BIOSCIENCES
155 north mccarthy boulevard
milpitas CA 95035
Manufacturer (Section G)
BECTON, DICKINSON AND COMPANY, BD BIOSCIENCES
155 north mccarthy boulevard
milpitas CA 95035
Manufacturer Contact
fahmy razak - mdr
155 north mccarthy boulevard
milpitas, CA 95035
8772328995
MDR Report Key21337680
Report Number3027394506-2025-00002
Device Sequence Number8624296
Product Code OYE
UDI-Device Identifier00382903389629
UDI-Public(01)00382903389629(11)130125
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
K141468
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Other,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 02/20/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Other
Device Catalogue Number338962
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/30/2025
Supplement Date Received by Manufacturer02/20/2025
Initial Report FDA Received Date02/07/2025
Supplement Report FDA Received Date02/21/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured01/25/2013
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-